With Reports of Death, FDA Warns Multiple Sclerosis (MS) Patients Against Pharmaceutical Drug Tysabri
Campaign launched to rally Multiple Sclerosis patients in potential class action lawsuit against the manufacturer of pharmaceutical drugs Tysabri and Avonex.
Wilmington, NC (PRWEB) July 14, 2005 -- Greg Jones & Associates, a North
Carolina-based law firm, in association with www.lawyersandsettlements.com, launches a marketing campaign
to increase awareness of the Multiple Sclerosis drug, Tysabri. Makers of
Tysabri, Biogen Idec Inc. and Elan Pharmaceuticals Inc., have recently taken the
drug off the market and sent out warnings to doctors.
In November 2004,
Biogen Idec and Elan Corporation received approval from the FDA to market and
distribute Tysabri (natalizumab). Only four months later, February 2005, the
drug was quickly removed from the market after the FDA received several reports
of severe illness and death in patients prescribed Tysabri and Avonex. In
several cases, the patient or corpse was allegedly diagnosed with Progressive
Multifocal Leukoencephalopathy (PML), a rare brain infection that directly
affects the central nervous system. Symptoms of PML are similar to a stroke:
headaches, memory loss, speech and vision difficulties, limb weakness, and
partial paralysis; the disease leads to coma then to death.
To date,
approximately 8,000 patients have been involved in clinical trials or prescribed
Tysabri for multiple sclerosis, Crohn's disease and rheumatoid arthritis. Biogen
Idec and Elan Pharmaceuticals hope to redistribute the drug after extensive
evaluations of Tysabri and the possible link to PML.
Biogen merged with
IDEC Pharmaceuticals in 2003, creating the billion-dollar company, Biogen Idec,
which is based in Cambridge, Massachusetts. Biogen Idec also has another MS drug
in the news: the bread-winning drug, Avonex, the most widely prescribed Multiple
Sclerosis drug in the world with revenues of $1.4 billion in 2004 has recently
been linked to increased risk of liver damage and liver failure.
Greg
Jones & Associates is urging patients that have had adverse side effects
with the prescription drugs Tysabri or Avonex, to have their case reviewed at www.lawyersandsettlements.com; each case will be evaluated by
a lawyer at no charge.
For more details about this product recall and
potential class action lawsuit, visit
https://www.lawyersandsettlements.com/case/tysabri
About
Online Legal Services Ltd (OLS) and www.lawyersandsettlements.com
OLS is a privately held
Internet marketing company that specializes in joint advertising campaigns for
lawyers and law firms. Lawyersandsettlements.com offers a comprehensive website
with up-to-date information on legal news, class action lawsuits, personal
injury cases, settlement details, product recalls, and more. Consumers can
complete free case evaluations and subscribe to free newsletters.
Visit
us at:
http://www.lawyersandsettlements.com/
Contact us
at:
604-608-3435
# # #
Source : http://www.prweb.com/releases/2005/7/prweb256781.htm